Radiation therapy in the management of limited small cell lung cancer: When, where, and how much?

Chest

Volumn 113, Issue 1 SUPPL., 1998, Pages 92S-100S

  Wagner Jr , Henry ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; LOMUSTINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; HUMAN; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; REVIEW;

EID: 0031965433     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Bunn P, Ihde D. Small cell bronchogenic carcinoma: a review of therapeutic results. In: Livingston R, ed. Lung cancer 1. The Hague: Martinus Nijhoff, 1981: 169-208
2. Johnson D, Kim K, Sause W, et al. Cisplatin (P) and etoposide (E) + thoracic radiotherapy (TRT) administered once or twice daily (BID) in limited stage (LS) small cell lung cancer (SCLC): final results of Intergroup trial 009 [abstract 1113]. Proc Am Soc Clin Oncol 1996; 15:374
3. Feinstein A, Sosin D, Wells C. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985; 312:1604-08
4. Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? J Clin Oncol 1992; 10:890-95
5. Pignon JP, Arriadada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small cell lung cancer. N Engl J Med 1992; 327:1618-24
6. Pignon JP, Steward LA, Souhami RL, et al. A meta-analysis using individual patient data from randomized clinical trials (RCTs) of chemotherapy (CT) in non-small cell lung cancer (NSCLC): (2) survival in the locally advanced (LA) setting [abstract]. Proc Am Soc Clin Oncol 1994; 13:334
7. Murray N, Coldman A. The relationship between thoracic irradiation timing and long-term survival in combined modality therapy of limited small cell lung cancer [abstract]. Proc Am Soc Clin Oncol 1995; 14:1099A
8. Perry M, Eaton WL, Propert KJ, et al. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med 1987; 316:912-18
9. Perry MC, Herndon JE, Eaton WL, et al. Thoracic radiation therapy added to chemotherapy in limited small cell lung cancer: an update of Cancer and Leukemia Group B (CALGB) study 8083 [abstract 1150]. Proc Am Soc Clin Oncol 1996; 15:384
10. Murray N, Coy P, Pater JL, et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. J Clin Oncol 1993; 11:336-44
11. Schultz H. Timing of chest irradiation with respect to combination chemotherapy in small cell lung cancer, limited disease [abstract]. Lung Cancer 1988; 4:153
12. Takada M, Fukuoka M, Furuse K, et al. Phase III study of concurrent versus sequential thoracic radiotherapy (TRT) in combination with cisplatin (C) and etopside (E) for limited-stage (LS) small cell lung cancer: preliminary results of the Japanese Clinical Oncology Group [abstract 1103]. Proc Am Soc Clin Oncol 1996; 15:372
13. Gregor A. Phase III comparison of alternating and sequential radiation therapy and CDE chemotherapy for limited SCLC. Presented at the International Association for the Study of Lung Cancer, Bruges, Belgium, 1996
14. LeBeau B, Chastang CI, Urban T, et al. A randomized clinical trial comparing concurrent and alternated thoracic irradiation in limited small cell lung cancer (SCLC) [abstract 1148]. Proc Am Soc Clin Oncol 1996; 15:383
15. Arriagada R, Kramar A, Le Chevalier T, et al. Competing events determining relapse-free survival in limited small cell lung carcinoma. J Clin Oncol 1992; 10:447-51
16. Arriagada R, Le Chevalier T, Ruffie P, et al. Alternating radiotherapy and chemotherapy in limited small cell lung cancer: the IGR protocols. French FNCLCC Lung Cancer Study Group. Lung Cancer 1994; 10(suppl 1):289-98
17. Choi N, Carey R. Importance of radiation dose in achieving improved locoregional tumor control in limited stage small cell lung carcinoma: an update. Int J Radiat Oncol Biol Phys 1989; 17:307-10
18. Coy P, Hodson DI, Murray N, et al. Patterns of failure following locoregional radiotherapy in the treatment of limited stage small cell lung cancer (see Comments). Int J Radiat Oncol Biol Phys 1994; 28:355-62
19. Carney D, Mitchell J, Kinsella T. In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variant. Cancer Res 1983; 43:2806-11
20. Turrisi A, Glover D, Mason B. A preliminary report: concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer. Int J Radiat Oncol Biol Phys 1988; 15:183-87
21. Turrisi A, Wagner H, Glover DJ, et al. Limited small cell lung cancer (LSCLC): concurrent BID thoracic radiotherapy (TR) with platinum-etoposide (PE): an ECOG study [abstract 5]. Proc Am Soc Clin Oncol 1990; 9:230
22. Johnson BE. Concurrent approaches to combined chemotherapy and chest radiotherapy for the treatment of patients with limited stage small cell lung cancer [review]. Lung Cancer 1994; 10(suppl 1):281-87
23. Johnson D, Turrisi AT, Chang AY, et al. Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group. J Clin Oncol 1993; 11:879-84
24. Shaw E, So J, Eagan R, et al. Analysis of long term survival and impact of prophylactic cranial irradiation (PCI) in complete responders with small cell lung cancer (SCLC): analysis of the Mayo Clinic (MC) and North Central Cancer Treatment Group (NCCTG) data bases [abstract 1088]. Proc Am Soc Clin Oncol 1993; 12:328
25. Armstrong J, Shank B, Scher H, et al. Limited small cell lung cancer: do favorable short-term results predict ultimate outcome? Am J Clin Oncol 1991; 14:285-90
26. Arriagada R, Le Chevalier T, Borie F, et al. Randomized trial on prophylactic cranial irradiation (PCI) for patients (pts) with small cell lung cancer (SCLC) in complete remission ((JR) [abstract 1108]. Proc Am Soc Clin Oncol 1994; 13:334
27. Hansen H, Dombernowsky P, Hirsch FR, et al. Prophylactic irradiation in bronchogenic small cell anaplastic carcinoma: a comparative trial of localized versus extensive radiotherapy including prophylactic brain irradiation in patients receiving combination chemotherapy. Cancer 1980; 46:279-84
28. Anr RJ, Simone J, Hustes HO, et al. Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia. Blood 1971; 37:272
29. Jackson D, Richards F, Cooper MR, et al. Prophylactic cranial irradiation in small cell carcinoma of the lung. JAMA 1977; 237:2730-33
30. Cox J, Stanley K, Petrovich Z, et al. Cranial irradiation in cancer of the lung of all cell types. JAMA 1981; 245:469-72
31. Maurer L, Tulloh M, Weiss RB, et al. A randomized combined modality trial in small cell carcinoma of the lung: comparison of combination chemotherapy-radiation therapy versus cyclophosphamide-radiation therapy: effects of maintenance chemotherapy and prophylactic whole brain irradiation. Cancer 1980; 45:30-39
32. Niiranen A, Holsti P, Salmo M. Treatment of small cell lung cancer: two-drug versus four-drug chemotherapy and locoregional irradiation with or without prophylactic cranial irradiation. Acta Oncol 1989; 28:501-05
33. Beiler D, Kane RC, Bernath AM, et al. Low dose elective brain irradiation in small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 1979; 5:944-45
34. Eagan R, Lee RE, Frytak S, et al. Thoracic radiation therapy and Adriamycin/cisplatin containing chemotherapy for locally advanced non-small cell lung cancer. Cancer Clin Trials 1981; 2:381-88
35. Seydel H, Creech R, Pagano M, et al. Prophylactic versus no brain irradiation in regional small cell lung carcinoma. Am J Clin Oncol 1985; 8:218-23
36. Arriagada R, Le Chevalier T, Borie F, et al. Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission. J Natl Cancer Inst 1995; 87:183-90
37. Gregor A, Cull A, Stephens RJ, et al. Effects of prophylactic cranial irradiation (PCI) in small cell lung cancer (SCLC) results of UKCCCR/EORTC randomized trial [abstract 1139]. Proc Am Soc Clin Oncol 1996; 15:381
38. Wagner H, Kim K, Turrisi AT, et al. A randomized phase III trial of prophylactic cranial irradiation (PCI) vs observation (OBS) in patients (Pts) with small cell lung cancer (SCLC) achieving a complete response: final report of an incomplete trial by the Eastern Cooperative Oncology Group and Radiation Therapy Oncology Group (E3589/R92-01) [abstract 1120]. Proc Am Soc Clin Oncol 1996; 15:376
39. Aisner J, Whitacre M, Van Echo DA, et al. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant regimens. Cancer Treat Rep 1982; 66:221-30
40. Cataire R, Schwade JG, Yarr I, et al. Follow-up neurological evaluation in patients with small cell lung carcinoma treated with prophylactic cranial irradiation and chemotherapy. Int J Radiat Oncol Biol Phys 1981; 7:105-09
41. Chak L, Zatz UM, Wasserstein P, et al. Neurologic dysfunction in patients treated for small cell carcinoma of the lung: a clinical and radiological study. Int J Radiat Oncol Biol Phys 1986; 12:385-89
42. Crossen J, Garwood D, Glatstein E, et al. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 1994; 12:627-42
43. Cull A, Gregor A, Hopwood P, et al. Neurological and cognitive impairment in long-term survivors of small cell lung cancer. Eur J Cancer 1994; 30A:1067-74
44. Frytak S, Eagan RT, Therneau TM, et al. Leukoencephalopathy (LE) in patients with small cell lung cancer (SCLC) receiving prophylactic cranial irradiation (PCI) [abstract] Proc Am Soc Clin Oncol 1987; 10:686
45. Johnson B, Becker B, Goff WB, et al. Neurologic, neuropsychologic, and cranial computed tomography scan abnormalities in 2-10 year survivors of small cell lung cancer. J Clin Oncol 1985; 3:1659-67
46. Johnson B, Petronas N, Hayes W, et al. Neurologic, computed cranial tomographic, and magnetic resonance imaging abnormalities in patients with small cell lung cancer: further follow-up of 6 to 13-year survivors. J Clin Oncol 1990, 8:46-56
47. Lee J, Umsawasdi T, Lee Y, et al. Neurotoxicity in long term survivors of small cell lung cancer. Int J Radiat Oncol Biol Phys 1986; 12:313-21
48. Licciardello J, Gerosimo RJ, Karp DD, et al. Disturbing central nervous system complications following combination chemotherapy and prophylactic whole-brain irradiation in patients with small cell lung cancer. Cancer Treat Rep 1985; 69:1429-30
49. Lishner M, Feld R, Payne DG, et al. Late neurologic complications after prophylactic cranial irradiation in patients with small cell lung cancer: the Toronto experience. J Clin Oncol 1990; 8:215-21
50. Turrisi A. Brain irradiation and systemic chemotherapy for small-cell lung cancer: dangerous liaisons? [editorial]. J Clin Oncol 1990; 8:196-99
51. Cull A, Gregor A, Hopwood P, et al. Neurological and cognitive impairment in long-term survivors of small cell lung cancer. Eur J Cancer 1994; 30A: 1067-74
52. Koniaki R, Meyers CA, Shin DM, et al. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 1995; 33:179-82
53. van Oosterhout A, van de Pol M, ten Velde GPM, et al. Neurologic disorders in 203 consecutive patients with small cell lung cancer: results of a longitudinal study. Cancer 1996; 77:1434-41